Peer-to-Peer Programs and Pharma Launches: Opportunities to Engage HCPs Using Short-Form, Trusted, Clinically Relevant Information with Andrew Willmer, EVP of Strategy and Innovation at Symbiotix

Peer-to-peer programs bring together clinical experts from the same field to share information and expertise on a specific pharma subject. Lately, there has emerged a high demand for clinically experienced doctors and experts to discuss with their peers and give advice to each other. In this episode of Pharma Launch Secrets, Bozidar is joined by Andrew Willmer, EVP of Strategy and Innovation at Symbiotix.

Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide

In this episode, Bozidar is joined by Andrew Willmer, EVP of Strategy and Innovation at Symbiotix.

They cover:

What are the three most common forms of P2P programs?
Why are short clinical pearls coming from a trusted voice, delivered in a personalized way, the future of HCP engagement?
What is one feature that HCPs request for virtual, real-time, and on-demand P2P engagement programs?

Subscribe here:

And connect with the host and guest here:

Bozidar Jovicevic: https://www.linkedin.com/in/bjovicevic
Evermed: https://evermedtv.com
Andrew Willmer: https://www.linkedin.com/in/andy-willmer-7bb5071/
Symbiotix: https://www.symbiotix.com/

About The Show:

“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.